Intravitreal Aflibercept 40 mg/ml
Original notice title
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Aflibercept is a biologic product requiring specific handling and storage; potential supply chain issues.
Price-only award may lead to unsustainable pricing.
Submission deadline in 6 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 12.1M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration 24 MONTH
- Supply of medicinal products Aflibercept (ATC S01LA05) 40 mg/ml for intravitreal administration
- Framework agreement for 24 months
Show full summary
Open tender for a framework agreement for the supply of Aflibercept (ATC S01LA05) intravitreal 40 mg/ml medicinal products to Slovak health insurance company Všeobecná zdravotná poisťovňa. 5 lots, each for a 24-month framework. Award to lowest price. Estimated total value €12,126,560. Deadline 30 June 2026. Electronic submission via Josephine Proebiz. Documents available on UVO portal.
Risks
Aflibercept is a biologic product requiring specific handling and storage; potential supply chain issues.
Price-only award may lead to unsustainable pricing.
Submission deadline in 6 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Electronic submission required
- Submission languages: Slovak or Czech
- Tenders must be submitted via Josephine Proebiz platform
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Lot 4
Lot 5
Buyer
Name
Všeobecná zdravotná poisťovňa, a.s.
Location
Bratislava - mestská časť Petržalka, SVK
Buyer profile
Identifier
35937874
Lots (5)
LOT-0001
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml, časť 1
Supply of Aflibercept 40 mg/ml for intravitreal administration, part 1
EUR 3.8M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
LOT-0002
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml časť 2
Supply of Aflibercept 40 mg/ml for intravitreal administration, part 2
EUR 2M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
LOT-0003
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml časť 3
Supply of Aflibercept 40 mg/ml for intravitreal administration, part 3
EUR 2M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
LOT-0004
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml časť 4
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
EUR 2M
Estimated value
Location
Duration
Category
Selection criteria
Award details
LOT-0005
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml časť 5
Lieky ATC skupiny S01LA05, Aflibercept, intravitreálne 40 mg/ml
EUR 2.2M
Estimated value
Location
Duration
Category
Selection criteria
Award details
Procurement Details
- Publication date
- 27 May 2026
- Notice type
- Contract notice — standard
- Languages
- Slovak, Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 365426-2026
- Source notice ID
- 5fcf4009-d090-40eb-a49d-8c2e6f69721c
Documents (2)
Similar tenders
Poland – Immunosuppressive agents – Dostawa środków immunosupresyjnych, produktów leczniczych dla układu nerwowego, produktów leczniczych dla organów zmysłów, środków leczniczych dla układu oddechowego, produktów leczniczych dla przewodu pokarmowego i metabolizmu, produktów leczniczych stosowanych przy cukrzycy, insuliny, płynów dożylnych, ogólnoustrojowych preparatów hormonalnych, z wyłączeniem hormonów płciowych oraz różnych...
Slovakia – Medicinal products for sensory organs – Liečivá pre zmyslové orgány
Romania – Pharmaceutical products – FURNIZARE PRODUSE SI PREPARATE FARMACEUTICE 2026
Poland – Antineoplastic agents – Dostawa środków przeciwnowotworowych, przeciwgrzybicznych środkach bakteryjnych, różnych produktów leczniczych, środków przeciwbólowych, produktów leczniczych dla organów zmysłu, produktów leczniczych dla dermatologii, w podziale na 85 części.
Poland – Antibacterials for systemic use – Dostawy produktów leczniczych - antybiotyki
Slovakia – Medicinal products for sensory organs – Liečivá pre zmyslové orgány
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Aflibercept is a biologic product requiring specific handling and storage; potential supply chain issues.
Price-only award may lead to unsustainable pricing.
Submission deadline in 6 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications